Current Vascular Pharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 2
Author(s): Dimitrios N. Tziakas
Affiliation:
Export Options
About this article
Cite this article as:
Tziakas N. Dimitrios , Meet Our Editorial Board Member, Current Vascular Pharmacology 2018; 16 (2) . https://dx.doi.org/10.2174/157016111602180126100954
DOI https://dx.doi.org/10.2174/157016111602180126100954 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Knowledge about Medicine Use in Pregnancy: A National Study among Pharmacy Students in Jordan
Current Reviews in Clinical and Experimental Pharmacology The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Uric Acid in Metabolic and Cerebrovascular Disorders: A Review
Current Vascular Pharmacology In Vitro Dissolution Testing of Drug-Eluting Stents
Current Pharmaceutical Biotechnology Association Between Vitamin D Serum Level and Depression
Current Psychopharmacology Mild Systemic Inflammation has a Neuroprotective Effect After Stroke in Rats
Current Neurovascular Research The Role of Folate-supplementation in Depression: A Narrative Review
Current Psychopharmacology Nitroxides as Cancer Imaging Agents
Anti-Cancer Agents in Medicinal Chemistry A New Drug Candidate (GEMSP) for Multiple Sclerosis
Current Medicinal Chemistry The Effects of Calorie Restriction in Depression and Potential Mechanisms
Current Neuropharmacology Ghrelin, A Novel Peptide Hormone in the Regulation of Energy Balance and Cardiovascular Function
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Obstructive Sleep Apnea Syndrome: An Emerging Risk Factor for Dementia
CNS & Neurological Disorders - Drug Targets Influence of Essential Trace Minerals and Micronutrient Insufficiencies on Harmful Metal Overload in a Mongolian Patient with Multiple Sclerosis
Current Aging Science Recent Developments in Antiplatelet Therapy after Percutaneus Coronary Intervention
Cardiovascular & Hematological Disorders-Drug Targets Modulation of Potassium Channels as a Therapeutic Approach
Current Pharmaceutical Design Virtual Screening-Based Discovery of Potent Hypoglycemic Agents: In Silico, Chemical Synthesis and Biological Study
Current Computer-Aided Drug Design Drug Tissue Distribution: Study Methods and Therapeutic Implications
Current Pharmaceutical Design A Simple and Precise Determination of Diltiazem Hydrochloride by Simultaneous Conductometric and Potentiometric Detection
Current Pharmaceutical Analysis ER Stress and UPR in Familial Amyotrophic Lateral Sclerosis
Current Molecular Medicine Vitamin D Metabolites and/or Analogs: Which D for Which Patient?
Current Vascular Pharmacology